Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|June 3, 2010
Barriers to participation in cancer prevention clinical trialsMichael J Hall, Brian Egleston, Suzanne M Miller, et al.Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.Urology|November 8, 2011
Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal massDaniel Canter, Alexander Kutikov, Brandon Manley, et al.Urology|June 19, 2012
Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumorsMarc C Smaldone, Alexander Kutikov, Brian Egleston, et al.Pediatric Exercise Science|November 12, 2014
Youth and young adult physical activity and body composition of young adult women: findings from the dietary intervention study in childrenMelissa G Hodge, Mary Hovinga, John A Shepherd, et al.JAMA Otolaryngology-- Head & Neck Surgery|October 22, 2020
Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare PatientsChase C Hansen, Brian Egleston, Brooke K Leachman, et al.Urologic Oncology|March 18, 2015
Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?Reza Mehrazin, Marc C Smaldone, Brian Egleston, et al.Annals of Surgical Oncology|September 11, 2014
Coupling of prostate and thyroid cancer diagnoses in the United StatesJeffrey J Tomaszewski, Robert G Uzzo, Brian Egleston, et al.Urology|August 11, 2021
Feasibility and Outcomes of Renal Mass Biopsy for Anatomically Complex Renal TumorsSelma Masic, Marshall Strother, Laura C Kidd, et al.Medical Care|November 8, 2016
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry DataMarc C Smaldone, Brian Egleston, John M Hollingsworth, et al.Pageof 6